Cordatus Wealth Management LLC United Therapeutics Corp Transaction History
Cordatus Wealth Management LLC
- $417 Million
- Q3 2025
A detailed history of Cordatus Wealth Management LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Cordatus Wealth Management LLC holds 1,067 shares of UTHR stock, worth $475,273. This represents 0.11% of its overall portfolio holdings.
Number of Shares
1,067
Previous 1,063
0.38%
Holding current value
$475,273
Previous $305,000
46.56%
% of portfolio
0.11%
Previous 0.08%
Shares
10 transactions
Others Institutions Holding UTHR
# of Institutions
751Shares Held
43.4MCall Options Held
340KPut Options Held
318K-
Black Rock Inc. New York, NY5.47MShares$2.44 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$1.98 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$1.06 Billion12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$965 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$944 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $20.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...